InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（10 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
10
T+90 胜率
0%
T+90 平均收益
-13.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Henderson Jeffrey William, Director. Insider active across 5 companies, notably Halozyme Therapeutics, INC.. In total, 31 disclosures have been recorded. Breakdown: 1 buy · 10 sells. Total volume traded: €2m. History available since 5 May 2021. The latest transaction was filed on 17 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Henderson Jeffrey William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报31 总计
2,563 股0Common StockSEC:0000804328-26-000038:0
2,355 股0Common StockSEC:0000804328-26-000025:0
1,098 股0Common StockSEC:0001628280-26-004019:0
4,165 股0Common StockSEC:0001415889-25-011771:0
4,297 股@ US$60.33716.7% 占其流量Common StockSEC:0001415889-25-011432:0
503 股@ US$64.052.2% 占其流量Common StockSEC:0001415889-25-009440:0
2,097 股0Common StockSEC:0001888316-25-000025:0
1,901 股0Common StockSEC:0001888316-25-000015:0
1,795 股@ US$57.9347.3% 占其流量Common StockSEC:0001415889-25-006323:0
1,500 股@ US$233.62100.0% 占其流量Common StockSEC:0001062993-25-001977:0
标准退出：2025年5月11日 (T+90)
1,100 股@ US$55.9434.4% 占其流量Common StockSEC:0001415889-25-003006:0
930 股0Common StockSEC:0001062993-25-001300:0
10,000 股@ US$50.00635.7% 占其流量Common StockSEC:0001415889-25-000995:0
6,501 股0Common StockSEC:0001415889-24-011685:0
2,056 股0Common StockSEC:0001888316-24-000029:0
900 股0Common StockSEC:0001062993-24-001307:0
2,000 股@ US$1.0318.5% 占其流量Common StockSEC:0001209191-23-048554:0
2,000 股@ US$1.9134.0% 占其流量Common StockSEC:0001209191-23-045087:0
2,000 股@ US$2.6947.6% 占其流量Common StockSEC:0001209191-23-042247:0
8,289 股0Common StockSEC:0001209191-23-036074:0
8,065 股0Common StockSEC:0001415889-23-007691:0
3,316 股0Common StockSEC:0001888316-23-000026:0
10,000 股@ US$48.5133.6% 占其流量Common StockSEC:0001415889-23-003703:0
2,500 股@ US$124.0529100.0% 占其流量Common StockSEC:0001888316-23-000008:0
848 股0Common StockSEC:0001062993-23-001435:0
31 条申报中的 25 条
About Henderson Jeffrey William
Henderson Jeffrey William is a Director at Halozyme Therapeutics, INC., QUALCOMM INC/DE, Becton Dickinson & Co, FibroGen Inc and Qualcomm Inc/de. He has 31 filings in total, and across the sampled recent filings from 2021-05-06 to 2026-03-18, the reported amounts are EUR 339840 of buys and EUR 1660819 of sells, with Attribution as the modal transaction nature.
